Sensei Biotherapeutics, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 1405 RESEARCH BLVD, SUITE 125, ROCKVILLE, MD, 20850
Mailing Address 1405 RESEARCH BLVD, SUITE 125, ROCKVILLE, MD, 20850
Phone (240) 243-8000
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
$74.37M
Total Assets
$9.48M
Total Liabilities
$103.41M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 4 Insider stock transaction report | December 10, 2025 | View on SEC |
| 4 Insider stock transaction report | December 10, 2025 | View on SEC |
| 4 Insider stock transaction report | December 8, 2025 | View on SEC |
| 4 Insider stock transaction report | December 8, 2025 | View on SEC |
| 3 Initial insider ownership report | November 24, 2025 | View on SEC |
| 8-K Current report of material events | November 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 30, 2025 | View on SEC |
Insider Trading
STRONG SELL 2 insiders
16 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.